Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Magenta Therapeutics, Inc. (MGTA) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Fairmount Funds Management LLC (10% Owner) has filed a Form 4 on Dianthus Therapeutics, Inc. /DE/
Txns: Bought 24,670 shares @ $13.63, valued at $336.3k
09/28/2023 4 Fairmount Funds Management LLC (10% Owner) has filed a Form 4 on Dianthus Therapeutics, Inc. /DE/
Txns: Bought 30,000 shares @ $13.15, valued at $394.5k
02/09/2023 4 Third Rock Ventures IV, L.P. (10% Owner) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Sold 2,200,000 shares @ $0.83, valued at $1.8M
Sold 1,500,000 shares @ $0.82, valued at $1.2M
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2022 4 Olson Lisa (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $1.57, valued at $157k
08/01/2022 4 Beetham Thomas W. (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 75,000 options to buy @ $1.57, valued at $117.8k
08/01/2022 4 Humphrey Jeffrey (Chief Medical Officer) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 75,000 options to buy @ $1.57, valued at $117.8k
08/01/2022 4 GARDNER JASON (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 187,500 options to buy @ $1.57, valued at $294.4k
08/01/2022 4 Nichols David Wayne (Chief Technical Officer) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 75,000 options to buy @ $1.57, valued at $117.8k
08/01/2022 4 Mahoney Stephen F. (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 130,000 options to buy @ $1.57, valued at $204.1k
08/01/2022 4 Stants Kristen (Chief People Officer) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 85,000 options to buy @ $1.57, valued at $133.5k
08/01/2022 4 Deardorf Caren (Chief Commercial Officer) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 75,000 options to buy @ $1.57, valued at $117.8k
06/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2022 4 Scadden David (Director) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $1.21, valued at $24.2k
06/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2022 4 GARDNER JASON (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 3,000 shares @ $0.99, valued at $3k
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2022 4 Olson Lisa (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 50,000 options to buy @ $1.18, valued at $59k
05/19/2022 4 Humphrey Jeffrey (Chief Medical Officer) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 50,000 options to buy @ $1.18, valued at $59k
05/19/2022 4 GARDNER JASON (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 162,500 options to buy @ $1.18, valued at $191.8k
05/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy